ES2913376R1 - Compuestos de curcumina y aminoacidos basicos - Google Patents

Compuestos de curcumina y aminoacidos basicos

Info

Publication number
ES2913376R1
ES2913376R1 ES202290022A ES202290022A ES2913376R1 ES 2913376 R1 ES2913376 R1 ES 2913376R1 ES 202290022 A ES202290022 A ES 202290022A ES 202290022 A ES202290022 A ES 202290022A ES 2913376 R1 ES2913376 R1 ES 2913376R1
Authority
ES
Spain
Prior art keywords
curcumine
compounds
amino acids
basic amino
basic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES202290022A
Other languages
English (en)
Other versions
ES2913376A2 (es
ES2913376B2 (es
Inventor
Chavez Jorge Guillermo Dominguez
Vazquez Karina Mondragon
Pelaez Juan Pablo Senosiain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alparis SA de CV
Original Assignee
Alparis SA de CV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis SA de CV filed Critical Alparis SA de CV
Publication of ES2913376A2 publication Critical patent/ES2913376A2/es
Publication of ES2913376R1 publication Critical patent/ES2913376R1/es
Application granted granted Critical
Publication of ES2913376B2 publication Critical patent/ES2913376B2/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES202290022A 2019-09-06 2020-07-31 Compuestos de curcumina y aminoacidos basicos Active ES2913376B2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2019010692A MX393732B (es) 2019-09-06 2019-09-06 Compuestos de curcumina y aminoácidos básicos.
PCT/IB2020/057240 WO2021044231A2 (es) 2019-09-06 2020-07-31 Compuestos de curcumina y aminoácidos básicos

Publications (3)

Publication Number Publication Date
ES2913376A2 ES2913376A2 (es) 2022-06-01
ES2913376R1 true ES2913376R1 (es) 2022-06-15
ES2913376B2 ES2913376B2 (es) 2023-07-10

Family

ID=74852489

Family Applications (1)

Application Number Title Priority Date Filing Date
ES202290022A Active ES2913376B2 (es) 2019-09-06 2020-07-31 Compuestos de curcumina y aminoacidos basicos

Country Status (9)

Country Link
US (1) US20220370391A1 (es)
AU (1) AU2020341121B2 (es)
CA (1) CA3153397C (es)
CO (1) CO2022003583A2 (es)
ES (1) ES2913376B2 (es)
GB (1) GB2616919B (es)
MX (1) MX393732B (es)
PE (1) PE20221255A1 (es)
WO (1) WO2021044231A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021016108A (es) * 2021-12-17 2023-06-19 Alparis Sa De Cv Combinacion farmaceutica para el tratamiento de enfermedades respiratorias infecciosas y enfermedades contraidas por via aerea.
CN115569233B (zh) * 2022-10-17 2023-07-14 湖南大学 既能吸光又能与自由基反应的高效光抑制剂的制备方法
CN117137066A (zh) * 2023-08-30 2023-12-01 江门职业技术学院 一种杀灭副溶血性弧菌的组合物及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130109754A1 (en) * 2010-05-04 2013-05-02 Laboratorios Senosiain S.A. De C.V. Combination of an nsaid and an amino acid
US20140031403A1 (en) * 2011-04-05 2014-01-30 Van Andel Research Institute Solid Forms of Curcumin
WO2015052568A2 (en) * 2013-10-07 2015-04-16 Laurus Labs Private Limited Solid forms of curcumin and derivatives thereof
WO2015085351A1 (en) * 2013-12-12 2015-06-18 Newsouth Innovations Pty Limited Pharmaconutrient composition
EP3437638A1 (en) * 2017-08-01 2019-02-06 Inpha Duemila S.r.l. Nervonic acid and curcumin for the treatment of pathologies associated with peripheral nerves trophism alterations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303328B1 (en) * 2008-05-29 2017-12-20 Universite Libre De Bruxelles Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
ITUB20153895A1 (it) * 2015-09-25 2017-03-25 Pasquale Gualdiero Associazione di curcumina, arginina e vitamina d
US10336677B2 (en) * 2016-03-25 2019-07-02 Biopteq Sprl Curcumin purification

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130109754A1 (en) * 2010-05-04 2013-05-02 Laboratorios Senosiain S.A. De C.V. Combination of an nsaid and an amino acid
US20140031403A1 (en) * 2011-04-05 2014-01-30 Van Andel Research Institute Solid Forms of Curcumin
WO2015052568A2 (en) * 2013-10-07 2015-04-16 Laurus Labs Private Limited Solid forms of curcumin and derivatives thereof
WO2015085351A1 (en) * 2013-12-12 2015-06-18 Newsouth Innovations Pty Limited Pharmaconutrient composition
EP3437638A1 (en) * 2017-08-01 2019-02-06 Inpha Duemila S.r.l. Nervonic acid and curcumin for the treatment of pathologies associated with peripheral nerves trophism alterations

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GOUD N RAJESH ET AL. Fast dissolving eutectic compositions of curcumin. International Journal of Pharmaceutics , 03/10/2012, Vol. 439, Páginas 63-72 (DOI: doi:10.1016/j.ijpharm.2012.09.045) pág. 63 col. 2, pág. 65 col. 1 y 2 y Esquema 1. *
KARAGIANNI A. ET AL. Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery. Pharmaceutics , 19/07/2018, Vol. 10, (DOI: doi:10.3390/pharmaceutics10030098) sección 3.3.1, 3.3.2 y 3.4. *
PARVATHY K S ET AL. Curcumin-amino acid conjugates: Synthesis, antioxidant and antimutagenic attributes. Food Chemistry, 23/10/2009, Vol. 120, Páginas 523-530 (DOI: doi:10.1016/j.foodchem.2009.10.047) pág. 523 columnas 1 y 2 y Tabla 1 y 2. *
WANG R. ET AL. Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine. International Journal of Pharmaceutics, 25/02/2019, Vol. 561, Páginas 9-18 (DOI: doi:10.1016/j.ijpharm.2019.02.027) sección 3.1.1 y resumen. *

Also Published As

Publication number Publication date
ES2913376A2 (es) 2022-06-01
ES2913376B2 (es) 2023-07-10
US20220370391A1 (en) 2022-11-24
GB202204938D0 (en) 2022-05-18
WO2021044231A3 (es) 2021-06-24
GB2616919A (en) 2023-09-27
GB2616919B (en) 2024-07-24
CA3153397C (en) 2023-06-20
AU2020341121B2 (en) 2025-10-09
MX393732B (es) 2025-03-19
CA3153397A1 (en) 2021-03-11
WO2021044231A2 (es) 2021-03-11
CO2022003583A2 (es) 2022-04-19
AU2020341121A1 (en) 2022-04-14
MX2019010692A (es) 2022-07-06
PE20221255A1 (es) 2022-08-16
BR112022004059A2 (pt) 2022-05-31

Similar Documents

Publication Publication Date Title
IL286373A (en) Protein tyrosine phosphatase inhibitor compounds and uses thereof
IL285178A (en) Compounds and uses thereof
IL285461A (en) Processes and compounds
IL282998A (en) Pyridazinone compounds and uses thereof
EP3626699A4 (en) SSAO INHIBITOR
EP3497086A4 (en) AMINOPYRIMIDINE SSAO INHIBITORS
IL278122B1 (en) Pteridinone compounds and uses thereof
EP3856381A4 (en) LEGED ROBOT
EP3412941A4 (en) POETRY
DK3470409T3 (da) Benzotriazol-afledt Alfa- og Beta-umættet amidforbindelse anvendt som TGF-BRI-hæmmer
DK3796896T3 (da) Farmaceutisk adrenalinformulering
DK3737402T5 (da) Modificeret protein
IL285118A (en) Compounds and uses thereof
DK4259617T3 (da) Substituerede pyrazolpiperidincarboxylsyrer
IL284514A (en) Halo-allylamine compounds and use thereof
EP3746430A4 (en) INHIBITORS OF PROTEIN ARGININE DEIMINASES
IL288871A (en) Novel non-coding heterocyclic amino acids (nchaa) and their use as herbicides
DK3840767T3 (da) Peptider
ES2913376R1 (es) Compuestos de curcumina y aminoacidos basicos
EP3511598A4 (en) POETRY
EP3892301A4 (en) KLK5 INHIBITOR PEPTIDE
CA189120S (fr) Pendentif
EP3781820C0 (de) Strukturierte gashaltende oberflächen
IL282676A (en) Novel dipeptide compounds and uses thereof
EP3755376A4 (en) FORMULATIONS CONTAINING PROTEASIS AFFECTING THE MUCINE

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2913376

Country of ref document: ES

Kind code of ref document: A2

Effective date: 20220601

EC2A Search report published

Ref document number: 2913376

Country of ref document: ES

Kind code of ref document: R1

Effective date: 20220608

FG2A Definitive protection

Ref document number: 2913376

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20230710